This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Weisheng Chen, Ph.D.
Founder and CEO at Leveragen


Dr. Weisheng Chen is the Founder and CEO of Leveragen, Inc., a Boston-based early-stage biotech company developing next-generation genetic models for antibody discovery. Dr. Chen received his PhD degree from the University of Michigan under the mentorship of molecular geneticist Philippe Soriano, and carried out his postdoc research with molecular biology pioneer Tom Maniatis at Harvard and Columbia. Prior to founding Leveragen in 2017, Dr. Chen was a founding scientist and genetic models group leader at Kallyope, Inc.

Agenda Sessions

  • Networking Luncheon, Exhibit and Poster Viewing